Your browser doesn't support javascript.
loading
Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.
Borges, Camilla de S; Ferreira, Aline F; Almeida, Vitor H; Gomes, Fausto G; Berzoti-Coelho, Maria Gabriela; Cacemiro, Maira da Costa; Nunes, Natalia S; Figueiredo-Pontes, Lorena L; Simões, Belinda P; Castro, Fabíola A; Monteiro, Robson Q.
Afiliação
  • Borges CS; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Ferreira AF; Department of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Almeida VH; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Gomes FG; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Berzoti-Coelho MG; Department of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Cacemiro MDC; Department of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Nunes NS; Department of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Figueiredo-Pontes LL; Hematology Division, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Simões BP; Hematology Division, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Castro FA; Department of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
  • Monteiro RQ; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: robsonqm@bioqmed.ufrj.br.
Exp Hematol ; 66: 50-62, 2018 10.
Article em En | MEDLINE | ID: mdl-30076949
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação Leucêmica da Expressão Gênica / Proteínas de Fusão bcr-abl / Receptor PAR-1 / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação Leucêmica da Expressão Gênica / Proteínas de Fusão bcr-abl / Receptor PAR-1 / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil